Unknown

Dataset Information

A novel approach to remove interference of therapeutic monoclonal antibody with serum protein electrophoresis.


ABSTRACT:

Objectives

Multiple myeloma (MM) is characterized by malignant growth of plasma cells, usually producing a monoclonal antibody (mAb). New treatments for MM include therapeutic monoclonal antibodies (tmAbs), but patients treated with tmAb demonstrate interference on serum electrophoresis (SPE) and immunoprecipitation electrophoresis (IEP). Evaluation of treatment efficacy and determination of MM remission include SPE and IEP which identifies mAb, but cannot differentiate between disease associated mAb and tmAb. We hypothesized that tmAb could be removed from patient sera before testing by SPE and IEP to provide accurate diagnoses for clinicians.

Design and methods

We developed the Antigen Specific therapeutic monoclonal Antibody Depletion Assay (ASADA), that utilizes magnetic

SUBMITTER: Liu L 

PROVIDER: S-EPMC6928417 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature